Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pneumonias and immunosuppression].

K Dalhoff1, J Marxsen, J Steinhoff

  • 1Medizinische Klinik III, Pulmologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck. klaus.dalhoff@uni-luebeck.de

Der Internist
|April 12, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2022
Same author

Challenges in conducting paediatric trials with off-patent drugs.

Contemporary clinical trials communications·2021
Same author

Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade.

Infection·2021
Same author

[Community-acquired pneumonia].

Der Pneumologe·2020
Same author

Higher chlorzoxazone clearance in obese children compared with nonobese peers.

British journal of clinical pharmacology·2018
Same author

[Epidemiology, Diagnosis and Treatment of Adult Patients with Nosocomial Pneumonia - Update 2017 - S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology].

Pneumologie (Stuttgart, Germany)·2018
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Diagnosing and treating pneumonia in immunocompromised patients requires a broad etiological approach. Early, targeted interventions based on imaging and microbiological data are crucial for patient outcomes.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Immunology

Context:

  • Pneumonia poses a significant threat to immunocompromised individuals, necessitating prompt diagnosis and treatment.
  • The range of causative agents for pneumonia is wider in immunocompromised patients compared to immunocompetent individuals.
  • Factors like the type and intensity of immunosuppression, prophylactic measures, and specific exposures guide diagnosis.

Purpose:

  • To outline diagnostic strategies for pneumonia in immunocompromised patients.
  • To emphasize the importance of a broad etiological assessment and targeted therapy.
  • To highlight the role of various diagnostic tools, from imaging to molecular tests.

Summary:

  • High-resolution computed tomography (HRCT) of the thorax is essential for diagnostic planning.

Related Experiment Videos

  • Flexible bronchoscopy with bronchoalveolar lavage (BAL) is the standard for pathogen isolation.
  • Invasive biopsies are considered based on individual risk factors and expected pathogens.
  • Non-invasive antigen and PCR tests aid in detecting difficult-to-cultivate pathogens like fungi and herpesviruses.
  • Initial antimicrobial therapy should be guideline-based and adjusted upon microbiological results.

    • Impact:

    • Facilitates timely and accurate diagnosis of pneumonia in immunocompromised patients.
    • Guides the selection of appropriate diagnostic methods, including imaging and bronchoscopy.
    • Supports the implementation of targeted antimicrobial strategies for improved patient management.
    • Enhances understanding of the broader etiological spectrum of pneumonia in this vulnerable population.